Latest GMAB Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Ram Selvaraju | HC Wainwright | Reiterates | Buy | $40.00 | |
| Ram Selvaraju | HC Wainwright | Reiterates | Buy | $38.00 → $40.00 +2.00 (5.3%) | |
| Michael Schmidt | Guggenheim | Maintains | Buy | $40.00 | |
| Matt Phipps | William Blair | Maintains | Buy | - | |
| Gregory Renza | Truist | Maintains | Buy | - | |
| Eva Fortea Verdejo | Wells Fargo | Reiterates | Buy | $40.00 | |
| Matt Phipps | William Blair | Maintains | Buy | - | |
| Kalpit Patel | Wolfe Research | Maintains | Buy | $32.00 | |
| Gregory Renza | Truist | Maintains | Buy | - | |
| PerPlexity Biotechnology | TipRanks - PerPlexity | Upgrades | Hold | $29.00 → $24.50 -4.50 (-15.5%) | |
| Anthropic Biotechnology | TipRanks - Anthropic | Reiterates | Hold | $28.00 → $24.50 -3.50 (-12.5%) | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Hold | $29.00 → $25.00 -4.00 (-13.8%) | |
| Eva Fortea Verdejo | Wells Fargo | Reiterates | Buy | $65.00 → $40.00 -25.00 (-38.5%) |
